Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-08-05 4:03 pm Purchase |
2024-07-26 | 13G | ProMIS Neurosciences, Inc. PMN |
GREAT POINT PARTNERS LLC | 3,005,698 9.990% |
3,005,698 (New Position) |
Filing History |
| 2024-07-18 4:10 pm Purchase |
2024-07-16 | 13G | Unicycive Therapeutics, Inc. UNCY |
GREAT POINT PARTNERS LLC | 8,559,000 9.990% |
8,559,000 (New Position) |
Filing History |
| 2024-06-05 10:45 am Purchase |
2024-05-31 | 13G | Context Therapeutics Inc. CNTX |
GREAT POINT PARTNERS LLC | 7,419,355 9.890% |
7,419,355 (New Position) |
Filing History |
| 2024-04-08 4:10 pm Purchase |
2024-04-01 | 13G | Outlook Therapeutics, Inc. OTLK |
GREAT POINT PARTNERS LLC | 2,231,324 9.990% |
2,231,324 (New Position) |
Filing History |
| 2024-02-14 4:39 pm Unchanged |
2023-12-31 | 13G | Zura Bio Limited ZURA |
GREAT POINT PARTNERS LLC | 3,295,000 7.560% |
0 (Unchanged) |
Filing History |
| 2024-02-14 4:39 pm Unchanged |
2023-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
GREAT POINT PARTNERS LLC | 2,792,927 9.990% |
0 (Unchanged) |
Filing History |
| 2024-02-14 4:38 pm Unchanged |
2023-12-31 | 13G | UroGen Pharma Ltd. URGN |
GREAT POINT PARTNERS LLC | 2,620,545 8.490% |
0 (Unchanged) |
Filing History |
| 2024-02-14 4:38 pm Purchase |
2023-12-31 | 13G | OptiNose, Inc. OPTN |
GREAT POINT PARTNERS LLC | 765,608 9.990% |
11,293 (+1.50%) |
Filing History |
| 2024-02-14 4:37 pm Purchase |
2023-12-31 | 13G | Neurogene Inc. NGNE |
GREAT POINT PARTNERS LLC | 994,229 7.750% |
25,000 (+2.58%) |
Filing History |
| 2024-02-14 4:37 pm Sale |
2023-12-31 | 13G | Heron Therapeutics, Inc. HRTX |
GREAT POINT PARTNERS LLC | 0 0.000% |
-6,360,161 (Position Closed) |
Filing History |
| 2024-02-14 4:37 pm Sale |
2023-12-31 | 13G | Precision BioSciences, Inc. DTIL |
GREAT POINT PARTNERS LLC | 0 0.000% |
-269,993 (Position Closed) |
Filing History |
| 2024-02-14 4:36 pm Purchase |
2023-12-31 | 13G | Avalo Therapeutics, Inc. AVTX |
GREAT POINT PARTNERS LLC | 2,085 0.260% |
2,085 (New Position) |
Filing History |
| 2024-02-14 4:36 pm Purchase |
2023-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
GREAT POINT PARTNERS LLC | 3,703,433 6.370% |
65,715 (+1.81%) |
Filing History |
| 2023-12-27 4:03 pm Purchase |
2023-12-18 | 13G | Neurogene Inc. NGNE |
GREAT POINT PARTNERS LLC | 969,229 7.560% |
969,229 (New Position) |
Filing History |
| 2023-10-12 4:04 pm Purchase |
2023-10-02 | 13G | VistaGen Therapeutics, Inc. VTGN |
GREAT POINT PARTNERS LLC | 2,792,927 9.990% |
2,792,927 (New Position) |
Filing History |
| 2023-09-15 1:39 pm Purchase |
2023-09-08 | 13G | UroGen Pharma Ltd. URGN |
GREAT POINT PARTNERS LLC | 2,620,545 8.510% |
2,620,545 (New Position) |
Filing History |
| 2023-06-16 1:31 pm Purchase |
2023-06-05 | 13G | Zura Bio Limited ZURA |
GREAT POINT PARTNERS LLC | 3,295,000 7.650% |
3,295,000 (New Position) |
Filing History |
| 2023-04-13 1:58 pm Purchase |
2022-11-02 | 13G | Heron Therapeutics, Inc. HRTX |
GREAT POINT PARTNERS LLC | 6,360,161 5.350% |
6,360,161 (New Position) |
Filing History |
| 2023-02-27 3:40 pm Purchase |
2023-02-17 | 13G | Precision BioSciences, Inc. DTIL |
GREAT POINT PARTNERS LLC | 269,993 7.300% |
143,283 (+113.08%) |
Filing History |
| 2023-02-14 5:00 pm Unchanged |
2022-12-31 | 13G | OptiNose, Inc. OPTN |
GREAT POINT PARTNERS LLC | 754,315 9.990% |
0 (Unchanged) |
Filing History |